Hepatitis B Virus Exposure and Liver Cancer Risk
Author Information
Author(s): S Okada, T Sato, T Okusaka, H Ishii, M Ikeda, H Nakasuka, H Kosakamoto, M Yoshimori, K Wakabayashi
Primary Institution: National Cancer Center Hospital
Hypothesis
Does past exposure to hepatitis B virus influence the risk of developing hepatocellular carcinoma in patients with chronic liver disease?
Conclusion
Past exposure to hepatitis B virus is a significant risk factor for hepatocellular carcinoma in Japanese patients with chronic liver disease.
Supporting Evidence
- 65% of HCC patients were anti-HBc positive compared to 43% of CLD controls.
- Anti-HBc positivity significantly increased the risk of developing HCC.
- Patients positive for anti-HBc alone had a higher risk of HCC compared to those with transient HBV infection.
Takeaway
If someone has had hepatitis B in the past, they might be more likely to get liver cancer, especially if they don't have signs of being immune to it.
Methodology
A hospital-based case-control study comparing 141 HCC patients with chronic liver disease to 151 controls with chronic liver disease but without HCC.
Potential Biases
Potential biases may arise from the case-control design and selection of participants.
Limitations
The study is limited to Japanese patients, and findings may not be generalizable to other populations.
Participant Demographics
141 HCC patients (110 men, 31 women) with a mean age of 61.4 years; 151 CLD controls (96 men, 55 women) with a mean age of 55.9 years.
Statistical Information
P-Value
0.01
Confidence Interval
95% CI
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website